Middle Eastern Penny Stocks With Promising Potential In September 2025

Recent developments in the Middle Eastern markets have seen a positive trend, with Gulf stocks rising after regional central banks mirrored the U.S. Federal Reserve's rate cut, signaling potential economic support and growth. For investors interested in exploring beyond well-known companies, penny stocks—typically representing smaller or newer entities—continue to present intriguing opportunities despite their vintage label. These stocks can offer surprising value when backed by solid financials and clear growth prospects, making them worth considering for those seeking potential long-term gains.

Top 10 Penny Stocks In The Middle East

Click here to see the full list of 80 stocks from our Middle Eastern Penny Stocks screener.

We'll examine a selection from our screener results.

United Fidelity Insurance Company (P.S.C.) (ADX:FIDELITYUNITED)

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: United Fidelity Insurance Company (P.S.C.) operates in the United Arab Emirates, offering a range of general and life insurance products, with a market cap of AED 256 million.

Operations: The company generates revenue from three main segments: Consumer (AED 184.48 million), Commercial (-AED 66.73 million), and Employee Benefits (AED 215.80 million).

Market Cap: AED256M

United Fidelity Insurance Company (P.S.C.) has shown recent progress, reporting a net income of AED 2.39 million for Q2 2025, compared to a significant loss in the previous year. Despite this improvement, the company remains unprofitable overall with an increasing debt-to-equity ratio and short-term liabilities exceeding assets. The management team is relatively new, averaging 1.7 years in tenure, which may impact strategic continuity. However, the company's cash position is strong enough to cover its obligations for over a year without additional funding if current cash flow trends persist.

• Click here to discover the nuances of United Fidelity Insurance Company (P.S.C.) with our detailed analytical financial health report.
• Assess United Fidelity Insurance Company (P.S.C.)'s previous results with our detailed historical performance reports.

Katmerciler Arac Üstü Ekipman Sanayi ve Ticaret (IBSE:KATMR)

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: Katmerciler Arac Üstü Ekipman Sanayi ve Ticaret A.S. operates in the manufacturing sector, specializing in vehicle-mounted equipment, with a market capitalization of TRY3.45 billion.

Operations: The company generates revenue primarily from its vehicle equipment manufacturing segment, amounting to TRY1.32 billion.

Market Cap: TRY3.45B

Katmerciler Arac Üstü Ekipman Sanayi ve Ticaret A.S. has demonstrated a turnaround, reporting TRY 62.19 million in net income for Q2 2025, reversing a loss from the previous year. The company's debt-to-equity ratio has significantly improved to 15.4% from very high levels over five years, indicating better financial health. Short-term assets of TRY9.9 billion comfortably cover both short and long-term liabilities, enhancing liquidity stability despite volatile share prices and low return on equity (10.3%). Earnings quality remains high with no recent shareholder dilution, although interest coverage by EBIT is slightly below optimal at 2.8x.

• Dive into the specifics of Katmerciler Arac Üstü Ekipman Sanayi ve Ticaret here with our thorough balance sheet health report.
• Gain insights into Katmerciler Arac Üstü Ekipman Sanayi ve Ticaret's historical outcomes by reviewing our past performance report.

Human Xtensions (TASE:HUMX-M)

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: Human Xtensions Ltd. is a medical robotics company in Israel that develops, manufactures, markets, and sells modular medical devices for minimally invasive surgical operations with a market cap of ₪7.38 million.

Operations: Currently, there are no reported revenue segments for this medical robotics company based in Israel.

Market Cap: ₪7.38M

Human Xtensions Ltd., a medical robotics company in Israel, is pre-revenue with less than US$1 million in revenue. Despite being unprofitable, it has reduced losses by 12.3% annually over the past five years and recently reported a net income of ₪0.52 million for H1 2025, reversing a significant loss from the previous year. The company is debt-free and its short-term assets exceed liabilities, though it faces high share price volatility and has less than one year of cash runway based on current free cash flow trends. The board is experienced with an average tenure of 4.6 years.

• Click to explore a detailed breakdown of our findings in Human Xtensions' financial health report.
• Evaluate Human Xtensions' historical performance by accessing our past performance report.

Seize The Opportunity

• Discover the full array of 80 Middle Eastern Penny Stocks right here.
• Ready To Venture Into Other Investment Styles? These 10 companies survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. Discover why before your portfolio feels the trade war pinch.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com